City

Chula Vista (1)

Graz (1)

Ljubljana (1)

Montreal (1)

Palo Alto (1)

Thessaloniki (1)

Condition

Type 1 Diabetes (3)

Diabetes Mellitus, Type 1 (2)

Hyperglycemia, Postprandial (1)

Type 1 Diabetes Mellitus (1)

Overall Status

Active, not recruiting (2)

Completed (2)

Unknown status (1)

Phase

n/a (2)

phase 4 (2)

phase 1 (1)

Sponsor

Arecor Limited (1)

Aristotle University Of Thessaloniki (1)

McGill University (1)

Stanford University (1)

University of Ljubljana, Faculty of Medicine (1)

Collaborator

Juvenile Diabetes Research Foundation (1)

Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz, Austria (1)

Medtronic (1)

UMC Ljubljana University Children's Hospital Ljubljana (1)

Intervention

fiasp (5)

novolog (2)

novorapid (2)

640g pump (1)

artificial pancreas (1)

at247 (1)

placebo (1)

pramlintide acetate (1)

Study Documents

Intervention Type

drug (5)

device (2)

Funder Type

Other (4)

Industry (1)

Study Type

Interventional (5)

fiasp

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes, Type 1 Trial in Chula Vista (AT247, NovoLog, Fiasp)

Active, not recruiting

Diabetes Mellitus, Type 1

AT247
+2 more

Chula Vista, California

ProSciento, Inc

Aug 12, 2022

Diabetes, Type 1 Trial in Palo Alto (Fiasp, Novolog)

Completed

Has Results

Diabetes Mellitus, Type 1

Fiasp
Novolog

Palo Alto, California
+1 more

Aug 16, 2021

Type 1 Diabetes, Type 1 Diabetes, Hyperglycemia, Postprandial Trial in Montreal (Fiasp, Pramlintide Acetate, Placebo)

Active, not recruiting

Type 1 Diabetes
+2 more

Fiasp
+3 more

Montreal, Quebec, Canada

3555 University Street

Jan 6, 2022

Type 1 Diabetes Trial in Graz, Ljubljana (Fiasp, Novorapid)

Completed

Type 1 Diabetes

Fiasp
Novorapid

Graz, Austria
+1 more

Sep 29, 2021

Type 1 Diabetes Trial in Thessaloniki (Fiasp, Novorapid, 640G pump)

Unknown status

Type 1 Diabetes

Fiasp
+2 more

Thessaloniki, Greece

Aristotle University of Thessaloniki

Nov 1, 2019